Arch Therapeutics's total assets for Q were $1.54M, a decrease of -15.47% from the previous quarter. ARTH total liabilities were $4.36M for the fiscal quarter, a 5.94% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.